Healthcare Equipment and Supplies
Company Overview of TheraDiag SA
TheraDiag SA engages in the development, industrialization, and marketing of diagnosis kits in France and internationally. It offers auto-immunity products, such as FIDIS kits that allow detection of multiple analytes from the same sample in a single assay; immunofluorescence tests to screen and identify the auto-antibodies; ELISA tests for performing various tests on the same plate; Chorus systems, compact multi-parametric analyzers; and immunoblot tests, which allow simultaneous detection of antibodies. The company also provides genetic tests comprising AmplideX products line for the diagnosis of the Fragile X syndrome; xTAG Gastrointestinal Pathogens Panel kits for identifying various gas...
4-6 Bd de Beaubourg
CS 90136 Croissy Beaubourg
Founded in 1986
Key Executives for TheraDiag SA
Chief Executive Officer and Director
Total Annual Compensation: $328.8K
Compensation as of Fiscal Year 2013.
TheraDiag SA Key Developments
Theradiag and Hospira Sign Partnership Agreement
May 20 15
Theradiag announced it has entered into a partnership agreement with Hospira regarding the supply of LISA-TRACKER CE-marked infliximab monitoring kit. Theradiag will supply and will also ensure installation and training in laboratories and provide information and follow-up with clinicians on behalf of Hospira. LISA TRACKER infliximab kits have been validated for use with Inflectra®.
TheraDiag SA Enters into Exclusive Distribution Agreement with Somagen Diagnostics
May 11 15
TheraDiag SA announced that it has entered into an exclusive distribution agreement with Somagen Diagnostics Inc., for the launch in Canada of its biotherapy monitoring range LISA TRACKER. Canadian Health Authorities have positioned themselves in favor of biotherapy monitoring2. This positive recommendation should benefit sales of LISA TRACKER in the country. LISA TRACKER kits are currently registered for sale in the European Union, North Africa, the Middle-East, India3 and Australia. They were registered in Canada in 2014.
Theradiag Announces New Marne-La-Valle Facility
Mar 18 15
Theradiag announced that it has moved into its new Marne-La-Valle facility, in the Paris area. The company's new location offers over 3,200 square meters of R&D and production laboratories, and office space. This represents a 60% gain in floor space with no significant increase in rental costs. Two thirds of the increase in space is allocated to R&D and production facilities, which will allow the Company to increase the volume of production and automation of its proprietary products.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries